This Week: and lots more… Reporting by Noah Smith1 Here, we explore the latest twist in the battle over 4-OH-DiPT2 prodrug patents as a new player enters the fold: Terran Biosciences. Earlier this year we provided analysis of a lawsuit filed by Reunion Neuroscience (which was formerly part of Field Trip) against its competitor, Mindset Pharma. In its complaint (PDF), Reunion asserted that Mindset…

Source

Previous articleCOMPASS Pathways announces publication of positive data from treatment-resistant depression phase 2 clinical trial of COMP360 psilocybin alongside antidepressants in Nature journal, Neuropsychopharmacology
Next articleClearmind Medicine Announces Share-Based Payment for the Company’s Consultants